BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	755.13	724.53	587.28	649.16	437.45
Short-Term Investments	318.68	567.01	426.6	416.23	316.36
Cash & Cash Equivalents	1,074	1,292	1,014	1,065	753.81
Cash Growth	-16.86%	27.39%	-4.83%	41.33%	-30.48%
Receivables	633.7	461.32	373.4	448.35	377.4
Inventory	1,107	894.08	776.67	698.55	680.28
Other Current Assets	141.39	104.52	110.44	129.93	130.66
Total Current Assets	2,956	2,751	2,274	2,342	1,942
Property, Plant & Equipment	1,066	1,073	1,035	1,032	1,011
Long-Term Investments	611.14	333.84	507.79	285.47	411.98
Goodwill and Intangibles	490.9	534.77	584.85	613.47	653.62
Other Long-Term Assets	1,717	1,682	1,602	1,574	671.43
Total Long-Term Assets	3,886	3,624	3,730	3,506	2,748
Total Assets	6,842	6,375	6,005	5,848	4,690
Accounts Payable	683.15	572.96	498.27	492.55	570.62
Current Debt	493.88	0	0	0	361.88
Other Current Liabilities	0	15.93	48.23	0	0
Total Current Liabilities	1,177	588.88	546.5	492.55	932.5
Long-Term Debt	593.1	1,083	1,079	1,075	486.24
Other Long-Term Liabilities	119.94	100.02	113.53	174.33	148.92
Total Long-Term Liabilities	713.03	1,183	1,193	1,249	635.16
Total Liabilities	1,890	1,772	1,739	1,742	1,568
Total Debt	1,087	1,083	1,079	1,075	848.12
Debt Growth	0.36%	0.37%	0.37%	26.77%	2.13%
Retained Earnings	-621.55	-789.2	-930.76	-861.61	-1,720.71
Comprehensive Income	-28.79	-3.87	14.43	-16.14	20.16
Shareholders' Equity	4,952	4,603	4,266	4,106	3,122
Net Cash / Debt	-13.16	208.52	-65.2	-9.76	-94.31
Net Cash Per Share	-0.07	1.10	-0.36	-0.05	-0.53
Working Capital	1,779	2,163	1,728	1,850	1,010
Book Value Per Share	26.36	24.85	23.33	22.71	17.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).